Greater female longevity among individuals with weakened p53, who avoid cancer death (“Altered TP53 Regulation and Its Cancer Risks for Females and Males” section), remains to be interrogated with the promise of therapeutic relevance. This evidence concerns the gene TP53 and cancer.